| (AUD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 64.63M | -69.69% |
| Operating expense | — | — |
| Net income | 30.44M | -78.57% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NEU.AX returned +30.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +20.6% |
| 1 year | +30.8% |
| 5 years | +929.8% |
| 10 years | +2451.1% |
| All-time high | $24.97 (Nov 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NEU.AX would be worth today ›No. Neuren Pharmaceuticals Limited has not paid a dividend in the past 12 months.
Neuren Pharmaceuticals Limited is part of the Healthcare sector.
Neuren Pharmaceuticals Limited has a market cap of 2.85B AUD, based on the latest quote.
